Suppr超能文献

增生型糖尿病视网膜病变玻璃体切除术后硅油下视网膜前出血的分布、再吸收和并发症。

Distribution, reabsorption, and complications of preretinal blood under silicone oil after vitrectomy for severe proliferative diabetic retinopathy.

机构信息

Department of Ophthalmology, National Taiwan University Hospital, and Medical College, National Taiwan University, Taipei, Taiwan.

出版信息

Eye (Lond). 2012 Apr;26(4):601-8. doi: 10.1038/eye.2011.318. Epub 2012 Jan 6.

Abstract

PURPOSE

To examine the evolution and complications of preretinal hemorrhage under silicone oil after diabetic vitrectomy.

METHODS

A total of 44 cases of primary diabetic vitrectomy with silicone oil infusion were reviewed in a 3-year period. Intravitreal bevacizumab was used preoperatively for cases with active proliferation, and in all cases at the end of surgery. Intraoperative bleeding, postoperative extent of preretinal hemorrhage, blood reabsorption time, and reproliferation and treatment results were assessed.

RESULTS

Maximal blood distributed in thin and scattered patterns (23 cases), thick and localized patterns (10 cases), or thick and scattered patterns (10 cases) developed within 1 week after surgery, and was largely reabsorbed within a month with improved postoperative vision. Confluent blood extending to the midperiphery (one case) resulted in severe fibrosis and detachment. Complications included fibrotic plaque (two cases), and fibrous band and thick membrane (seven cases). Six cases underwent preretinal tissue removal. Vision improvement ≥ 3 lines was noted in three cases.

CONCLUSION

Most of the rebleeding occurred within the first post-op week, with gradual reabsorption in the posterior pole within 4 weeks; widespread confluent bleeding might result in severe reproliferation and detachment. A major complication of preretinal bleeding was the formation of preretinal fibrosis. Re-operation achieved a mild VA improvement.

摘要

目的

研究糖尿病玻璃体切除术后硅油下视网膜前出血的演变和并发症。

方法

回顾了 3 年内 44 例原发性糖尿病玻璃体切除术后硅油填充的病例。对于活跃增殖的病例,术前使用玻璃体内贝伐单抗,所有病例在手术结束时均使用。评估术中出血、术后视网膜前出血程度、血液吸收时间、再增殖和治疗结果。

结果

术后 1 周内,最大出血量呈薄而分散的模式(23 例)、厚而局限的模式(10 例)或厚而分散的模式(10 例),并在 1 个月内大部分吸收,术后视力改善。连续的血液延伸至中周(1 例)导致严重的纤维化和脱离。并发症包括纤维斑块(2 例)和纤维带和厚膜(7 例)。6 例行视网膜前组织切除术。3 例视力改善≥3 行。

结论

大多数再出血发生在术后第 1 周内,4 周内后极部逐渐吸收;广泛的连续出血可能导致严重的再增殖和脱离。视网膜前出血的主要并发症是视网膜前纤维化的形成。再次手术可轻度改善 VA。

相似文献

2
[Preretinal hemorrhage and prognosis following vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy].
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Mar;44(2):167-73. doi: 10.3785/j.issn.1008-9292.2015.03.008.
3
Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy.
Retina. 2009 Jun;29(6):768-74. doi: 10.1097/IAE.0b013e3181a3b7ef.
4
Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
J Ocul Pharmacol Ther. 2019 Apr;35(3):161-167. doi: 10.1089/jop.2018.0093. Epub 2019 Jan 22.
5
Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
J Ocul Pharmacol Ther. 2020 Jun;36(5):304-310. doi: 10.1089/jop.2019.0149. Epub 2020 Mar 18.
6
TRActional DIabetic reTInal detachment surgery with co-adjuvant intravitreal dexamethasONe implant: the TRADITION STUDY.
Acta Diabetol. 2019 Oct;56(10):1141-1147. doi: 10.1007/s00592-019-01357-y. Epub 2019 May 14.
7
Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. doi: 10.1007/s00417-010-1303-3. Epub 2010 Feb 5.
8
Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.
Eye (Lond). 2015 Sep;29(9):1199-203. doi: 10.1038/eye.2015.114. Epub 2015 Jul 10.
9
Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
Ophthalmology. 2009 May;116(5):927-38. doi: 10.1016/j.ophtha.2008.11.005. Epub 2009 Mar 9.
10
Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
Acta Ophthalmol. 2011 Nov;89(7):634-40. doi: 10.1111/j.1755-3768.2009.01821.x. Epub 2010 Jan 8.

引用本文的文献

1
Refining vitrectomy for proliferative diabetic retinopathy.
Graefes Arch Clin Exp Ophthalmol. 2023 Dec;261(12):3659-3670. doi: 10.1007/s00417-023-06134-w. Epub 2023 Jun 14.
2
Microincision phacoemulsification combined with sutureless transpupillary passive silicone oil removal.
Indian J Ophthalmol. 2021 Sep;69(9):2311-2316. doi: 10.4103/ijo.IJO_3538_20.
5
[Preretinal hemorrhage and prognosis following vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy].
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Mar;44(2):167-73. doi: 10.3785/j.issn.1008-9292.2015.03.008.
6
Anatomical and functional outcomes after Densiron 68 heavy silicone oil tamponade for complicated retinal detachment in Chinese eyes.
Int J Ophthalmol. 2014 Jun 18;7(3):469-73. doi: 10.3980/j.issn.2222-3959.2014.03.15. eCollection 2014.
7
Clinical and histological features of epiretinal membrane after diabetic vitrectomy.
Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):401-10. doi: 10.1007/s00417-013-2479-0. Epub 2013 Oct 15.

本文引用的文献

1
Reduction in dose of intravitreous bevacizumab before vitrectomy for proliferative diabetic retinopathy.
Arch Ophthalmol. 2011 Jan;129(1):106-7. doi: 10.1001/archophthalmol.2010.333.
5
Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):641-50. doi: 10.1007/s00417-009-1247-7. Epub 2009 Dec 12.
6
Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.
Eur J Ophthalmol. 2009 Sep-Oct;19(5):848-52. doi: 10.1177/112067210901900526.
7
Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy.
Retina. 2009 Jun;29(6):768-74. doi: 10.1097/IAE.0b013e3181a3b7ef.
8
Involvement of Müller glial cells in epiretinal membrane formation.
Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):865-83. doi: 10.1007/s00417-009-1082-x. Epub 2009 May 5.
9
Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
Am J Ophthalmol. 2008 Aug;146(2):211-217. doi: 10.1016/j.ajo.2008.04.028. Epub 2008 Jun 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验